Pacira BioSciences
PCRX
PCRX
272 hedge funds and large institutions have $2.67B invested in Pacira BioSciences in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 116 increasing their positions, 83 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
272
Holders Change
-11
Holders Change %
-3.89%
% of All Funds
4.7%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
22
Increased
116
Reduced
83
Closed
30
Calls
$3.31M
Puts
$5.79M
Net Calls
-$2.48M
Net Calls Change
+$10.2M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$84.7M |
| 2 |
Millennium Management
New York
|
$24.9M |
| 3 |
Jennison Associates
New York
|
$42.4M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
$17.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
$50.9M |
